NutriPEPA2 is a randomized, single-blind, prospective, multicenter trial, in two parallel arms to confirm that the adsorbent PEPA membrane may decrease mortality related to inflammation and malnutrition encountered in HD or HDF-treated stage 5 renal failure compared to a non-adsorbent synthetic membrane.
The objective of NutriPEPA2 study is to demonstrate that the use of an adsorbent membrane (PEPA-Poly Ester Poly Arylate synthetic co-polymer membrane) decreases undernutrition (often associated with inflammation) and consequently morbidity, comparing one year mortality in patients with Chronic Kidney Disease (CKD), with severe Protein-Energy Wasting (PEW), treated with dialysis using a non-adsorbent synthetic membrane (Polysulfone or Polyethersulfone) versus an adsorbent membrane (PEPA).
ESRD
PEPA
Ch Annonay
Annonay
MC
France
07103
Recruiting
Theradial
Published on BioPortfolio: 2019-12-10T01:21:05-0500
Effect of rEPO in FGF23 in ESRD Patients
To evaluate the effects of recombinant rEPO in plasma levels of Fibroblast Growth Factor 23 in ESRD patients in hemodialysis. Prospective cohort of ESRD patients in HD where changes in pl...
The clinical diagnosis of sleep apnea is difficult among ESRD patients since the characteristic clinical features of sleep apnea may be absent and since sleep-related symptoms, such as fat...
Malnutrition and altered protein catabolism are serious problems in renal failure and hemodialysis (HD) patients. The purpose of this study is to characterize the safety of GHRP-1/AG in su...
Fabry Disease Screening in ESRD Patients in West of France
Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.
Identifying New Therapeutic Targets for Lupus Treatment
Lupus is an autoimmune disease affecting mainly young women (9/1). Lupus nephritis (LN) occurs in 30% of the cases of lupus and is associated with end stage renal disease (ESRD) in 17 to 2...
As an important marine fish pathogen, Edwardsiella piscicida infects a broad range of fish species and causes substantial economic losses. The EsrA-EsrB two-component system is essential for the expre...
Hemodialysis Quality Metrics in the First Year Following a Failed Kidney Transplant.
Failure of a previously transplanted kidney is a common cause of end-stage renal disease (ESRD) and represents 5% of incident dialysis patients in the United States. Patients with native kidney failur...
Association of Race and Ethnicity with Vascular Access Type Selection and Outcomes.
Black end-stage renal disease (ESRD) patients represent 30.5% of the prevalent ESRD population in the United States, despite only accounting for 18% of the total population. Black patients are less li...
End-stage renal disease (ESRD) is increasing both globally and in Asia. Singapore has the fifth highest incidence of ESRD worldwide, a trend that is predicted to rise. Older patients with ESRD are fac...
Impact of Early Cannulation Grafts on Quality and Cost of Care for ESRD Patients.
The annual cost of care associated with end stage renal dialysis (ESRD) per patient on hemodialysis (HD) is approaching $100,000, with nearly $42 billion in national spend per year. Early cannulation ...
None available.
Quick Links
Advanced Search |
Login |
Subscribe |
RSS